glp-1 receptor agonist and dpp-4 inhibitor combination not recommended The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect DPP4 Inhibitors vs GLP-1 Agonists

This newly published case report describes pregnancy in lysinuric protein intolerance (LPI) complicated by established immune dysregulation, severe thrombocytopenia and episodes of hyperammonaemia, a combination not previously reported

It offers broader metabolic effects

Patient-specific factors including age, comorbidities, and ability to implement lifestyle modifications significantly influence appropriate treatment duration

Clinical relevance of antiexenatide antibodies: safety, efficacy and crossreactivity with longterm treatment

This finding was later combined with research by Joel Habener and jointly published in JCI

J., Tschp, M